{
    "nctId": "NCT02434367",
    "briefTitle": "The Effect of Walking on Fatigue During Radiotherapy in Breast Cancer Patients 65 and Older",
    "officialTitle": "Phase 2 Randomized Study of a Walking Intervention for Radiation-related Fatigue Among Breast Cancer Patients Receiving Adjuvant Radiation",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Fatigue",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Compare the change in treatment related fatigue from baseline to last week of radiotherapy between patients in the WWE intervention and usual care arms using the Fatigue Symptom Index (FSI).",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* \u226565 years of age\n* Histologically confirmed Stage I, II or III breast cancer status post breast surgery with or without adjuvant chemotherapy.\n* Scheduled to undergo hypofractionated or standard fractionated radiation therapy to the breast or chest wall.\n* English speaking.\n* IRB approved, signed written informed consent.\n* Approval from their treating radiation oncologist to engage in moderate-intensity physical activity. This will be obtained by the study research coordinator and documented on the study screening form (attached).\n* Patient-assessed ability to walk and engage in moderate physical activity Willing and able to meet all study requirements.\n\nExclusion Criteria:\n\n* One or more significant medical conditions that in the physician's judgment preclude participation in the walking intervention.\n* Receiving accelerated partial breast irradiation.\n* Unable to walk or engage in moderate-intensity physical activity.\n* Already participated in Walk with Ease Program.\n* Already actively walking (\u2265120 minutes per week).",
    "sex": "FEMALE",
    "minimumAge": "65 Years",
    "stdAges": "OLDER_ADULT"
}